The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 11

More JCP Articles

JCP
Concomitant LAIs and Time to Rehospitalization in Patients Receiving Clozapine
Original Research

May 1, 2024

Clozapine plus LAI antipsychotics was associated with lower risk of rehospitalization compared to both clozapine plus oral antipsychotics and clozapine monotherapy.
, ,
JCP
Clozapine Use and Specific Indications
Original Research

April 29, 2024

Clozapine initiation is uncommon in people with psychotic disorders who have experienced events suggesting clozapine is indicated, with even lower rates in Black and Hispanic patients.
, , , et al
JCP
Antisuicidal Effects of Ketamine in Patients With Comorbid AUD
Original Research

April 24, 2024

Intranasal ketamine induced rapid antidepressant effects versus placebo but did not significantly change suicidal ideation scores in patients with alcohol use disorder and suicidal ideation with past attempt.
, , , et al
JCP
Fully Remote Trial of tACS for Treatment of MDD
Original Research

April 22, 2024

Rapid improvement in depression was associated with tACS, particularly for women. Patients can use tACS treatment on their own at home, and it is associated with minimal adverse events.
, , , et al
JCP
Severity of Antipsychotic-Induced Cervical Dystonia by Algorithm-Based Rating System
Original Research

April 15, 2024

Rater consensus data were compared with deviation angle data using AI-based deviation angle measurement technology. With the range of tilt angles found in the study, the authors propose a…
, , , et al
JCP
Psychological Pain as a Risk Factor for Suicidal Ideation
Original Research

April 8, 2024

In inpatients with depression, psychological pain is a risk factor for suicidal ideation. Those with borderline personality disorder may experience more prominent and temporally unstable psychological pain, likely underlying…
, ,
JCP
Serotonin Syndrome and Dextromethorphan Toxicity Caused by Fluoxetine and Bupropion-Dextromethorphan Interaction
Case Report

April 3, 2024

Addition of bupropion-dextromethorphan (BUP/DXM) to existing fluoxetine treatment resulted in serotonin syndrome within 3 days, with symptoms prompting presentation to the ED 5 days after discontinuation of BUP/DXM.
,
JCP
SSRI Behavioral Activation, the Boxed Bolded Warning, and Neurodevelopmental Disorders
ASCP Corner

April 2, 2024

Mayank Gupta, MD, discusses SSRI use and the risk of behavioral activation and suicidality in people with autism spectrum disorders.
JCP
Valproate and Weight Gain: A New Look at an Old Problem
Commentary

March 27, 2024

Dr Goldberg comments on a recent cohort study demonstrating a dose relationship with weight gain liability for valproate.
JCP
Associations of Valproate Doses With Weight Gain in Psychiatric Patients
Original Research

March 27, 2024

Valproate dose increase of 500 mg was associated with a weight change of +0.52% per month over a year. No associations were found between valproate dose and blood glucose,…
, , , et al
JCP
Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?
Letter to the Editor

March 20, 2024

As choice of administration route is crucial during psychiatric emergencies, the authors stress the need for RCTs comparing onset of efficacy for agitation across different administration routes of the…
,
JCP
Effects of Prenatal Exposure to Second-Generation Antipsychotics on Development and Behavior in Preschool-Aged Children
Original Research

March 13, 2024

Outcomes of children exposed in utero to second-generation antipsychotics (SGAs) were compared to those of children unexposed to SGAs in a cohort of mothers with a history of psychiatric…
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe